{
    "id": 8046,
    "fullName": "CDKN2A R80*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "CDKN2A R80* results in a premature truncation of the Cdkn2a protein at amino acid 80 of 156. R80* is predicted to confer a loss of function to the Cdkn2a protein, as demonstrated by loss of Cdk binding (PMID: 8668202).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3108,
                    "pubMedId": 8668202,
                    "title": "Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/8668202"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1029,
        "geneSymbol": "CDKN2A",
        "terms": [
            "CDKN2A",
            "ARF",
            "CDK4I",
            "CDKN2",
            "CMM2",
            "INK4",
            "INK4A",
            "MLM",
            "MTS-1",
            "MTS1",
            "P14",
            "P14ARF",
            "P16",
            "P16-INK4A",
            "P16INK4",
            "P16INK4A",
            "P19",
            "P19ARF",
            "TP16"
        ]
    },
    "variant": "R80*",
    "createDate": "06/21/2015",
    "updateDate": "09/11/2018",
    "referenceTranscriptCoordinates": {
        "id": 105720,
        "transcript": "NM_000077",
        "gDna": "chr9:g.21971121G>A",
        "cDna": "c.238C>T",
        "protein": "p.R80*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3558,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a gastric carcinoma cell line harboring CDKN2A R80* was sensitive to Ibrance (palbociclib) both in culture and in cell line xenograft models (PMID: 26380006, PMID: 20952405).",
            "molecularProfile": {
                "id": 7936,
                "profileName": "CDKN2A R80*"
            },
            "therapy": {
                "id": 850,
                "therapyName": "Palbociclib",
                "synonyms": null
            },
            "indication": {
                "id": 5517,
                "name": "stomach carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3810,
                    "pubMedId": 26380006,
                    "title": "CDK4/6 inhibitor suppresses gastric cancer with CDKN2A mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26380006"
                },
                {
                    "id": 3811,
                    "pubMedId": 20952405,
                    "title": "COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20952405"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15204,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Verzenio (abemaciclib) treatment inhibited tumor growth in patient-derived xenograft (PDX) models of head and neck squamous cell carcinoma harboring wild-type CCND1 and CDKN2A R80* (PMID: 30380421).",
            "molecularProfile": {
                "id": 30829,
                "profileName": "CCND1 wild-type CDKN2A R80*"
            },
            "therapy": {
                "id": 802,
                "therapyName": "Abemaciclib",
                "synonyms": null
            },
            "indication": {
                "id": 5520,
                "name": "head and neck squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12822,
                    "pubMedId": 30380421,
                    "title": "Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30380421"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20475,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with pancreatic cancer harboring KRAS G12D and CDKN2A R80* demonstrated a partial response with a 31.7% decrease in lesion size by RECIST when treated with the combination of Kineret (anakinra), Ibrance (palbociclib), and Mekinist (trametinib) (PMID: 31782524).",
            "molecularProfile": {
                "id": 35186,
                "profileName": "CDKN2A R80* KRAS G12D"
            },
            "therapy": {
                "id": 9366,
                "therapyName": "Anakinra + Palbociclib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17853,
                    "pubMedId": 31782524,
                    "title": "Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31782524"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 7936,
            "profileName": "CDKN2A R80*",
            "profileTreatmentApproaches": [
                {
                    "id": 16317,
                    "name": "CDK Inhibitor (Pan)",
                    "profileName": "CDKN2A R80*"
                },
                {
                    "id": 16315,
                    "name": "CDK4/6 Inhibitor",
                    "profileName": "CDKN2A R80*"
                },
                {
                    "id": 16314,
                    "name": "CDK6 Inhibitor",
                    "profileName": "CDKN2A R80*"
                },
                {
                    "id": 16316,
                    "name": "CDK4 Inhibitor",
                    "profileName": "CDKN2A R80*"
                }
            ]
        },
        {
            "id": 30829,
            "profileName": "CCND1 wild-type CDKN2A R80*",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35186,
            "profileName": "CDKN2A R80* KRAS G12D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 105719,
            "transcript": "XM_011517679",
            "gDna": "chr9:g.21970966_21970968delGCGinsTCA",
            "cDna": "c.238_240delCGCinsTGA",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105721,
            "transcript": "NM_001195132",
            "gDna": "chr9:g.21971121G>A",
            "cDna": "c.238C>T",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105723,
            "transcript": "XM_011517676",
            "gDna": "chr9:g.21971121G>A",
            "cDna": "c.238C>T",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105724,
            "transcript": "XM_011517675",
            "gDna": "chr9:g.21971121G>A",
            "cDna": "c.238C>T",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105720,
            "transcript": "NM_000077",
            "gDna": "chr9:g.21971121G>A",
            "cDna": "c.238C>T",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 105722,
            "transcript": "XM_005251343",
            "gDna": "chr9:g.21970966_21970968delGCGinsTCA",
            "cDna": "c.238_240delCGCinsTGA",
            "protein": "p.R80*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}